BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17189184)

  • 1. SNIP1: Myc's new helper in transcriptional activation.
    Larsson LG
    Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc's other life: stem cells and beyond.
    Laurenti E; Wilson A; Trumpp A
    Curr Opin Cell Biol; 2009 Dec; 21(6):844-54. PubMed ID: 19836223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes.
    Fujii M; Lyakh LA; Bracken CP; Fukuoka J; Hayakawa M; Tsukiyama T; Soll SJ; Harris M; Rocha S; Roche KC; Tominaga SI; Jen J; Perkins ND; Lechleider RJ; Roberts AB
    Mol Cell; 2006 Dec; 24(5):771-783. PubMed ID: 17157259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acting locally and globally: Myc's ever-expanding roles on chromatin.
    Varlakhanova NV; Knoepfler PS
    Cancer Res; 2009 Oct; 69(19):7487-90. PubMed ID: 19773445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering MYC's full oncogenic potential in the hematopoietic system.
    Janz S
    Oncogene; 2005 May; 24(22):3541-3. PubMed ID: 15782131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyomavirus small T antigen transactivates genes by its ability to provoke the synthesis and the stabilization of MYC.
    Klucky B; Wintersberger E
    Oncogene; 2007 Sep; 26(43):6356-60. PubMed ID: 17438527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2 regulates Myc protein stability and activity.
    Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
    Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc goes global: new tricks for an old oncogene.
    Knoepfler PS
    Cancer Res; 2007 Jun; 67(11):5061-3. PubMed ID: 17545579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by c-Myc of ncRNA expression.
    Kenneth NS; White RJ
    Curr Opin Genet Dev; 2009 Feb; 19(1):38-43. PubMed ID: 19179065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.
    Hartman J; Edvardsson K; Lindberg K; Zhao C; Williams C; Ström A; Gustafsson JA
    Cancer Res; 2009 Aug; 69(15):6100-6. PubMed ID: 19602591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human beta-defensin 1 is regulated via c-Myc and the biological clock.
    Sherman H; Froy O
    Mol Immunol; 2008 Jun; 45(11):3163-7. PubMed ID: 18433872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
    Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc.
    Kurabe N; Katagiri K; Komiya Y; Ito R; Sugiyama A; Kawasaki Y; Tashiro F
    Oncogene; 2007 Aug; 26(38):5626-34. PubMed ID: 17334388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
    Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
    J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1.
    Andrews PG; Kennedy MW; Popadiuk CM; Kao KR
    Mol Cancer Res; 2008 Feb; 6(2):259-66. PubMed ID: 18314487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
    Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
    Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.